Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts

Background Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear. Objective To investigate the association between subclinical thyroid dysfunction and bone loss. Methods Individual participant data analysis...

Full description

Saved in:
Bibliographic Details
Published inJournal of internal medicine Vol. 283; no. 1; pp. 56 - 72
Main Authors Segna, D., Bauer, D. C., Feller, M., Schneider, C., Fink, H. A., Aubert, C. E., Collet, T.‐H., Costa, B. R., Fischer, K., Peeters, R. P., Cappola, A. R., Blum, M. R., Dorland, H. A., Robbins, J., Naylor, K., Eastell, R., Uitterlinden, A. G., Rivadeneira Ramirez, F., Gogakos, A., Gussekloo, J., Williams, G. R., Schwartz, A., Cauley, J. A., Aujesky, D. A., Bischoff‐Ferrari, H. A., Rodondi, N.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.01.2018
Subjects
Online AccessGet full text
ISSN0954-6820
1365-2796
1365-2796
DOI10.1111/joim.12688

Cover

Abstract Background Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear. Objective To investigate the association between subclinical thyroid dysfunction and bone loss. Methods Individual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946–2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid‐stimulating hormone [TSH] 0.45–4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50–19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%ΔBMD) from serial dual X‐ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random‐effects two‐step approach. Results Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person‐years of follow‐up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD = −0.18 (95% CI: −0.34, −0.02; I2 = 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = −0.14 (95% CI: −0.38, 0.10; I2 = 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: −0.30, 0.36; I2 = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = −0.59; [95% CI: −0.99, −0.19]) and total hip region (%ΔBMD = −0.46 [95% CI: −1.05, −0.13]). In contrast, SHypo was not associated with bone loss at any site. Conclusion Amongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk.
AbstractList Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear.BACKGROUNDSubclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear.To investigate the association between subclinical thyroid dysfunction and bone loss.OBJECTIVETo investigate the association between subclinical thyroid dysfunction and bone loss.Individual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946-2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid-stimulating hormone [TSH] 0.45-4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50-19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%ΔBMD) from serial dual X-ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random-effects two-step approach.METHODSIndividual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946-2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid-stimulating hormone [TSH] 0.45-4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50-19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%ΔBMD) from serial dual X-ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random-effects two-step approach.Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person-years of follow-up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD = -0.18 (95% CI: -0.34, -0.02; I2 = 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = -0.14 (95% CI: -0.38, 0.10; I2 = 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: -0.30, 0.36; I2 = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = -0.59; [95% CI: -0.99, -0.19]) and total hip region (%ΔBMD = -0.46 [95% CI: -1.05, -0.13]). In contrast, SHypo was not associated with bone loss at any site.RESULTSAmongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person-years of follow-up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD = -0.18 (95% CI: -0.34, -0.02; I2 = 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = -0.14 (95% CI: -0.38, 0.10; I2 = 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: -0.30, 0.36; I2 = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = -0.59; [95% CI: -0.99, -0.19]) and total hip region (%ΔBMD = -0.46 [95% CI: -1.05, -0.13]). In contrast, SHypo was not associated with bone loss at any site.Amongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk.CONCLUSIONAmongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk.
Background Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear. Objective To investigate the association between subclinical thyroid dysfunction and bone loss. Methods Individual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946–2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid‐stimulating hormone [TSH] 0.45–4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50–19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%ΔBMD) from serial dual X‐ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random‐effects two‐step approach. Results Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person‐years of follow‐up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD = −0.18 (95% CI: −0.34, −0.02; I2 = 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = −0.14 (95% CI: −0.38, 0.10; I2 = 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: −0.30, 0.36; I2 = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = −0.59; [95% CI: −0.99, −0.19]) and total hip region (%ΔBMD = −0.46 [95% CI: −1.05, −0.13]). In contrast, SHypo was not associated with bone loss at any site. Conclusion Amongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk.
Background Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear. Objective To investigate the association between subclinical thyroid dysfunction and bone loss. Methods Individual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946-2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid-stimulating hormone [TSH] 0.45-4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50-19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%[Delta]BMD) from serial dual X-ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random-effects two-step approach. Results Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person-years of follow-up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %[Delta]BMD = -0.18 (95% CI: -0.34, -0.02; I2 = 0%), with a nonstatistically significant pattern at the total hip: %[Delta]BMD = -0.14 (95% CI: -0.38, 0.10; I2 = 53%), but not at the lumbar spine: %[Delta]BMD = 0.03 (95% CI: -0.30, 0.36; I2 = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%[Delta] BMD = -0.59; [95% CI: -0.99, -0.19]) and total hip region (%[Delta]BMD = -0.46 [95% CI: -1.05, -0.13]). In contrast, SHypo was not associated with bone loss at any site. Conclusion Amongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk.
Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear. To investigate the association between subclinical thyroid dysfunction and bone loss. Individual participant data analysis was performed after a systematic literature search in MEDLINE/EMBASE (1946-2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid-stimulating hormone [TSH] 0.45-4.49 mIU/L), SHyper (TSH < 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50-19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentage BMD change (%ΔBMD) from serial dual X-ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random-effects two-step approach. Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) had SHypo and 284 (5.2%) had SHyper. During 36 569 person-years of follow-up, those with SHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD = -0.18 (95% CI: -0.34, -0.02; I = 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = -0.14 (95% CI: -0.38, 0.10; I = 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: -0.30, 0.36; I = 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = -0.59; [95% CI: -0.99, -0.19]) and total hip region (%ΔBMD = -0.46 [95% CI: -1.05, -0.13]). In contrast, SHypo was not associated with bone loss at any site. Amongst adults, SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk.
Author Gogakos, A.
Bauer, D. C.
Robbins, J.
Gussekloo, J.
Fischer, K.
Segna, D.
Schneider, C.
Fink, H. A.
Peeters, R. P.
Costa, B. R.
Uitterlinden, A. G.
Eastell, R.
Aujesky, D. A.
Cappola, A. R.
Naylor, K.
Rivadeneira Ramirez, F.
Collet, T.‐H.
Feller, M.
Williams, G. R.
Schwartz, A.
Cauley, J. A.
Bischoff‐Ferrari, H. A.
Rodondi, N.
Dorland, H. A.
Blum, M. R.
Aubert, C. E.
AuthorAffiliation 5 Service of Endocrinology, Diabetes and Metabolism, University Hospital of Lausanne, Lausanne, Switzerland
1 Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
15 Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, United States
6 Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
11 Department of Medicine, University of California Davis, Sacramento, United States
4 Department of Medicine, University of Minnesota, Minneapolis, United States
2 Departments of Medicine and Epidemiology & Biostatistics, University of California, San Francisco, United States
10 University of Pennsylvania School of Medicine, Philadelphia, PA, United States
9 Department of Internal Medicine & Department of Epidemiology, Erasmus Medical Center Rotterdam, The Netherlands
13 Department of Medicine, Imperial College London, London, United Kingdom
14 Department of Public Health and Prima
AuthorAffiliation_xml – name: 9 Department of Internal Medicine & Department of Epidemiology, Erasmus Medical Center Rotterdam, The Netherlands
– name: 12 Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom
– name: 1 Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
– name: 2 Departments of Medicine and Epidemiology & Biostatistics, University of California, San Francisco, United States
– name: 13 Department of Medicine, Imperial College London, London, United Kingdom
– name: 5 Service of Endocrinology, Diabetes and Metabolism, University Hospital of Lausanne, Lausanne, Switzerland
– name: 6 Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
– name: 11 Department of Medicine, University of California Davis, Sacramento, United States
– name: 7 Centre on Aging and Mobility, University of Zurich, Zurich, Switzerland
– name: 8 Department of Geriatrics, University Hospital Zurich, Zurich, Switzerland
– name: 14 Department of Public Health and Primary Care & Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands
– name: 4 Department of Medicine, University of Minnesota, Minneapolis, United States
– name: 3 Geriatric Research Education and Clinical Center, Minneapolis VA Health Care System, Minneapolis, MN, United States
– name: 15 Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, United States
– name: 10 University of Pennsylvania School of Medicine, Philadelphia, PA, United States
Author_xml – sequence: 1
  givenname: D.
  orcidid: 0000-0002-4315-6676
  surname: Segna
  fullname: Segna, D.
  organization: University of Bern
– sequence: 2
  givenname: D. C.
  surname: Bauer
  fullname: Bauer, D. C.
  organization: University of California
– sequence: 3
  givenname: M.
  surname: Feller
  fullname: Feller, M.
  organization: University of Bern
– sequence: 4
  givenname: C.
  surname: Schneider
  fullname: Schneider, C.
  organization: University of Bern
– sequence: 5
  givenname: H. A.
  surname: Fink
  fullname: Fink, H. A.
  organization: University of Minnesota
– sequence: 6
  givenname: C. E.
  surname: Aubert
  fullname: Aubert, C. E.
  organization: University of Bern
– sequence: 7
  givenname: T.‐H.
  surname: Collet
  fullname: Collet, T.‐H.
  organization: University Hospital of Lausanne
– sequence: 8
  givenname: B. R.
  surname: Costa
  fullname: Costa, B. R.
  organization: University of Bern
– sequence: 9
  givenname: K.
  surname: Fischer
  fullname: Fischer, K.
  organization: University Hospital Zurich
– sequence: 10
  givenname: R. P.
  surname: Peeters
  fullname: Peeters, R. P.
  organization: Erasmus Medical Center
– sequence: 11
  givenname: A. R.
  surname: Cappola
  fullname: Cappola, A. R.
  organization: University of Pennsylvania School of Medicine
– sequence: 12
  givenname: M. R.
  surname: Blum
  fullname: Blum, M. R.
  organization: University of Bern
– sequence: 13
  givenname: H. A.
  surname: Dorland
  fullname: Dorland, H. A.
  organization: University of Bern
– sequence: 14
  givenname: J.
  surname: Robbins
  fullname: Robbins, J.
  organization: University of California Davis
– sequence: 15
  givenname: K.
  surname: Naylor
  fullname: Naylor, K.
  organization: University of Sheffield
– sequence: 16
  givenname: R.
  surname: Eastell
  fullname: Eastell, R.
  organization: University of Sheffield
– sequence: 17
  givenname: A. G.
  surname: Uitterlinden
  fullname: Uitterlinden, A. G.
  organization: Erasmus Medical Center
– sequence: 18
  givenname: F.
  surname: Rivadeneira Ramirez
  fullname: Rivadeneira Ramirez, F.
  organization: Erasmus Medical Center
– sequence: 19
  givenname: A.
  surname: Gogakos
  fullname: Gogakos, A.
  organization: Imperial College London
– sequence: 20
  givenname: J.
  surname: Gussekloo
  fullname: Gussekloo, J.
  organization: Leiden University Medical Center
– sequence: 21
  givenname: G. R.
  surname: Williams
  fullname: Williams, G. R.
  organization: Imperial College London
– sequence: 22
  givenname: A.
  surname: Schwartz
  fullname: Schwartz, A.
  organization: University of California
– sequence: 23
  givenname: J. A.
  surname: Cauley
  fullname: Cauley, J. A.
  organization: University of Pittsburgh
– sequence: 24
  givenname: D. A.
  surname: Aujesky
  fullname: Aujesky, D. A.
  organization: University of Bern
– sequence: 25
  givenname: H. A.
  surname: Bischoff‐Ferrari
  fullname: Bischoff‐Ferrari, H. A.
  organization: University Hospital Zurich
– sequence: 26
  givenname: N.
  surname: Rodondi
  fullname: Rodondi, N.
  email: nicolas.rodondi@insel.ch
  organization: University of Bern
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29034571$$D View this record in MEDLINE/PubMed
BookMark eNp9kV1rFDEYhYNU7LZ64w-QAW-KMDWZyeeNUIoflUpv9Dpkkne6WWaSNZlpmX9vdrcVLWJuAnmfczhvzgk6CjEAQq8JPiflvN9EP56Thkv5DK1Iy1ndCMWP0AorRmsuG3yMTnLeYExazPELdNwo3FImyAqNFzlH683kY6g6mO4BQpXnzg4-eGuGalovKXpXuSX3c7B7zgRX2bUJt1D5oippqtEHSAV3ELKflt37NsW8haK4g8rGdUxTfome92bI8OrhPkU_Pn38fvmlvr75fHV5cV1bSqWsBe84OIfb1oDogTigVGCipGEOpMLSMkloR1WnFGd9iw1hgnFRpp3rrWxP0YeD73buRnAWwlTC6W3yo0mLjsbrvyfBr_VtvNNMtEqxncHZg0GKP2fIkx59tjAMJkCcsyaKEcapIqqgb5-gmzinUNYrlJBUUdKQQr35M9HvKI9NFAAfAFu-LSfotfXTvpYS0A-aYL0rW-_K1vuyi-TdE8mj6z9hcoDv_QDLf0j99ebq20HzCw2xvSY
CitedBy_id crossref_primary_10_1055_a_1951_1233
crossref_primary_10_1080_10408398_2022_2107997
crossref_primary_10_1016_j_jocd_2023_03_001
crossref_primary_10_3389_fendo_2024_1301213
crossref_primary_10_1016_S2213_8587_18_30026_3
crossref_primary_10_1016_S2213_8587_18_30028_7
crossref_primary_10_1093_jbmr_zjad005
crossref_primary_10_3803_EnM_2021_1066
crossref_primary_10_1016_S2213_8587_21_00285_0
crossref_primary_10_1089_ct_2018_30_374_376
crossref_primary_10_1210_clinem_dgz058
crossref_primary_10_1007_s12020_019_02110_9
crossref_primary_10_1089_ct_2022_34_385_388
crossref_primary_10_1007_s40618_020_01359_6
crossref_primary_10_1089_thy_2021_0179
crossref_primary_10_1016_j_ando_2020_04_010
crossref_primary_10_1111_cen_14330
crossref_primary_10_1515_hmbci_2018_0039
crossref_primary_10_2174_1573399816666200324152517
crossref_primary_10_1080_17446651_2019_1575727
crossref_primary_10_1080_03007995_2023_2165811
crossref_primary_10_1210_clinem_dgab548
crossref_primary_10_1007_s12018_018_9246_z
crossref_primary_10_3390_jcm9041034
crossref_primary_10_1007_s40618_021_01537_0
crossref_primary_10_3803_EnM_2023_1769
crossref_primary_10_1038_s41598_020_75776_1
crossref_primary_10_1016_j_bone_2022_116404
crossref_primary_10_1177_0300060520903666
crossref_primary_10_1080_17446651_2020_1738924
crossref_primary_10_3390_diagnostics10030149
crossref_primary_10_1007_s12020_025_04195_x
crossref_primary_10_1002_jbmr_3426
crossref_primary_10_3389_fendo_2021_641560
crossref_primary_10_1016_j_beem_2022_101614
crossref_primary_10_1007_s11102_024_01437_5
crossref_primary_10_3389_fpsyt_2022_774251
crossref_primary_10_1007_s42000_024_00555_w
crossref_primary_10_1016_j_fmc_2021_04_008
crossref_primary_10_1186_s12902_021_00715_8
crossref_primary_10_1515_cclm_2024_0848
crossref_primary_10_1007_s00198_021_06081_4
crossref_primary_10_3389_fendo_2023_1306232
crossref_primary_10_1186_s12902_024_01779_y
crossref_primary_10_1097_SLA_0000000000002922
crossref_primary_10_2139_ssrn_4175923
crossref_primary_10_1007_s00198_021_05964_w
crossref_primary_10_1038_s41574_023_00911_7
crossref_primary_10_2478_bhk_2024_0001
crossref_primary_10_1530_EJE_18_0991
crossref_primary_10_1007_s12020_020_02259_8
crossref_primary_10_1007_s41999_021_00544_x
crossref_primary_10_3803_EnM_2022_1573
Cites_doi 10.1016/S2213-8587(13)70045-7
10.1001/jama.2015.3656
10.1210/jcem.87.2.8182
10.1210/jc.2014-1051
10.1097/MED.0000000000000204
10.1210/jc.2015-3191
10.1111/j.1365-2265.2007.03016.x
10.1093/epirev/mxt012
10.1056/NEJM199503233321202
10.1038/nrendo.2015.71
10.1001/jama.291.2.228
10.1007/s00198-011-1768-x
10.1016/j.beem.2011.12.004
10.1136/bmj.c221
10.1007/s00198-015-3259-y
10.1089/105072503322238854
10.1359/jbmr.070814
10.1001/archinternmed.2012.402
10.1530/EJE-13-0546
10.1210/er.2006-0043
10.1007/BF02390832
10.1007/s00198-015-3221-z
10.1016/0197-2456(86)90046-2
10.7326/0003-4819-140-2-200401200-00015
10.1016/j.cct.2005.05.006
10.1001/jama.2015.5161
10.1002/jbmr.1774
10.1359/JBMR.050304
10.1371/journal.pone.0081124
10.1210/jc.2011-3058
10.1191/1740774505cn087oa
10.1093/eurheartj/ehu424
10.1186/1472-6823-11-15
10.1111/jgs.12267
10.1089/thy.2006.16.375
10.1016/0140-6736(93)92555-8
10.1210/jc.2009-2630
10.1002/jbmr.2416
10.1001/jama.2010.1361
ContentType Journal Article
Copyright 2017 The Association for the Publication of the Journal of Internal Medicine
2017 The Association for the Publication of the Journal of Internal Medicine.
Copyright © 2018 The Association for the Publication of the Journal of Internal Medicine
Copyright_xml – notice: 2017 The Association for the Publication of the Journal of Internal Medicine
– notice: 2017 The Association for the Publication of the Journal of Internal Medicine.
– notice: Copyright © 2018 The Association for the Publication of the Journal of Internal Medicine
CorporateAuthor the Thyroid Studies Collaboration
Thyroid Studies Collaboration
CorporateAuthor_xml – name: the Thyroid Studies Collaboration
– name: Thyroid Studies Collaboration
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
C1K
K9.
7X8
5PM
DOI 10.1111/joim.12688
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

ProQuest Health & Medical Complete (Alumni)
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2796
EndPage 72
ExternalDocumentID PMC5739958
29034571
10_1111_joim_12688
JOIM12688
Genre article
Meta-Analysis
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: Sanofi‐Aventis
– fundername: Erasmus University, Rotterdam
– fundername: National Institute of Neurological Disorders and Stroke (NINDS)
– fundername: Dutch Ministry for Health, Welfare and Sports
– fundername: Municipality of Rotterdam
– fundername: Erasmus MC
– fundername: European Commission (DG XII)
– fundername: National Institute of Nursing Research
  funderid: R01‐NR012459
– fundername: Netherlands Organisation for the Health Research and Development (ZonMw)
– fundername: Eli Lilly
– fundername: NHLBI NIH HHS
  grantid: N01 HC085082
– fundername: NIA NIH HHS
  grantid: U01 AG042143
– fundername: NHLBI NIH HHS
  grantid: U01 HL080295
– fundername: NHLBI NIH HHS
  grantid: N01 HC055222
– fundername: NIA NIH HHS
  grantid: N01 AG062103
– fundername: Medical Research Council
  grantid: MR/P020941/1
– fundername: NINR NIH HHS
  grantid: R01 NR012459
– fundername: NIA NIH HHS
  grantid: R01 AG028050
– fundername: NIA NIH HHS
  grantid: U01 AG042124
– fundername: NIAMS NIH HHS
  grantid: K24 AR051895
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29K
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IPNFZ
IX1
J0M
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SJN
SUPJJ
TEORI
TR2
UB1
V8K
V9Y
VH1
VVN
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZCG
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QL
C1K
K9.
7X8
5PM
ID FETCH-LOGICAL-c4488-76b6edd033ae7fe1de4470198a5de8908c5814b49b9965f30a1575675debdfc83
IEDL.DBID DR2
ISSN 0954-6820
1365-2796
IngestDate Thu Aug 21 18:45:07 EDT 2025
Fri Jul 11 07:31:32 EDT 2025
Sat Jul 26 01:20:05 EDT 2025
Mon Jul 21 06:04:05 EDT 2025
Tue Jul 01 00:45:36 EDT 2025
Thu Apr 24 23:07:04 EDT 2025
Wed Jan 22 16:40:35 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords thyroid disease
hyperthyroidism
hypothyroidism
bone loss
bone density
prospective studies
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2017 The Association for the Publication of the Journal of Internal Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4488-76b6edd033ae7fe1de4470198a5de8908c5814b49b9965f30a1575675debdfc83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Daniel Segna, MD, Department of General Internal Medicine, Bern University Hospital, Bern, Switzerland. daniel.segna@insel.ch
Backup contact
ORCID 0000-0002-4315-6676
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/joim.12688
PMID 29034571
PQID 1978494121
PQPubID 30713
PageCount 17
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5739958
proquest_miscellaneous_1951564919
proquest_journals_1978494121
pubmed_primary_29034571
crossref_citationtrail_10_1111_joim_12688
crossref_primary_10_1111_joim_12688
wiley_primary_10_1111_joim_12688_JOIM12688
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2018
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: January 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Journal of internal medicine
PublicationTitleAlternate J Intern Med
PublicationYear 2018
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2013; 28
2013; 1
2010; 304
2006; 16
2015; 100
2015; 30
2004; 140
2013; 61
2015; 11
2003; 13
2011; 11
2005; 20
2013; 169
2010; 340
1995; 332
2005; 26
2013; 8
2001; 68
1993; 341
2012; 97
2012; 172
2004; 291
1986; 7
2015; 313
2008; 29
2002; 87
2015; 22
2014; 36
2008; 23
2007; 6
2014; 35
2008; 68
2016
2005; 2
2012; 26
2016; 27
2012; 23
2014; 99
2010; 95
e_1_2_9_30_1
e_1_2_9_31_1
e_1_2_9_11_1
e_1_2_9_34_1
Deure WM (e_1_2_9_35_1) 2008; 68
e_1_2_9_10_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_14_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_19_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_42_1
e_1_2_9_20_1
e_1_2_9_40_1
e_1_2_9_22_1
e_1_2_9_21_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_23_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
Belaya ZE (e_1_2_9_39_1) 2007; 6
e_1_2_9_9_1
e_1_2_9_26_1
e_1_2_9_25_1
e_1_2_9_28_1
e_1_2_9_27_1
e_1_2_9_29_1
References_xml – volume: 11
  start-page: 418
  year: 2015
  end-page: 28
  article-title: Short‐term and long‐term effects of osteoporosis therapies
  publication-title: Nat Rev Endocrinol
– volume: 27
  start-page: 203
  year: 2016
  end-page: 10
  article-title: Fracture prediction from repeat BMD measurements in clinical practice
  publication-title: Osteoporos Int
– volume: 313
  start-page: 2055
  year: 2015
  end-page: 65
  article-title: Subclinical thyroid dysfunction and fracture risk: a meta‐analysis
  publication-title: JAMA
– volume: 23
  start-page: 1699
  year: 2012
  end-page: 710
  article-title: The effects of adiponectin and leptin on changes in bone mineral density
  publication-title: Osteoporos Int
– volume: 172
  start-page: 799
  year: 2012
  end-page: 809
  article-title: Subclinical hyperthyroidism and the risk of coronary heart disease and mortality
  publication-title: Arch Intern Med
– volume: 26
  start-page: 569
  year: 2005
  end-page: 85
  article-title: Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study–a large observational study of the determinants of fracture in older men
  publication-title: Contemp Clin Trials
– volume: 332
  start-page: 767
  year: 1995
  end-page: 73
  article-title: Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group
  publication-title: N Engl J Med
– volume: 6
  start-page: 62
  year: 2007
  end-page: 70
  article-title: Subclinical hyperthyroidism of variable etiology and its influence on bone in postmenopausal women
  publication-title: Hormones (Athens)
– volume: 2
  start-page: 209
  year: 2005
  end-page: 17
  article-title: Meta‐analysis of individual patient data from randomized trials: a review of methods used in practice
  publication-title: Clin Trials
– volume: 341
  start-page: 72
  year: 1993
  end-page: 5
  article-title: Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group
  publication-title: Lancet
– volume: 304
  start-page: 1365
  year: 2010
  end-page: 74
  article-title: Subclinical hypothyroidism and the risk of coronary heart disease and mortality
  publication-title: JAMA
– volume: 87
  start-page: 489
  year: 2002
  end-page: 99
  article-title: Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
  publication-title: J Clin Endocrinol Metab
– volume: 340
  start-page: c221
  year: 2010
  article-title: Meta‐analysis of individual participant data: rationale, conduct, and reporting
  publication-title: BMJ
– volume: 26
  start-page: 431
  year: 2012
  end-page: 46
  article-title: Natural history, diagnosis and management of subclinical thyroid dysfunction
  publication-title: Best Pract Res Clin Endocrinol Metab
– volume: 8
  start-page: e81124
  year: 2013
  article-title: Effectiveness of bisphosphonate analogues and functional electrical stimulation on attenuating post‐injury osteoporosis in spinal cord injury patients‐ a systematic review and meta‐analysis
  publication-title: PLoS ONE
– volume: 35
  start-page: 3336
  year: 2014
  end-page: 45
  article-title: Systematic reviews and meta‐analyses of randomized trials: principles and pitfalls
  publication-title: Eur Heart J
– year: 2016
– volume: 99
  start-page: 2657
  year: 2014
  end-page: 64
  article-title: Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study
  publication-title: J Clin Endocrinol Metab
– volume: 13
  start-page: 585
  year: 2003
  end-page: 93
  article-title: Hyperthyroidism, bone mineral, and fracture risk–a meta‐analysis
  publication-title: Thyroid
– volume: 27
  start-page: 115
  year: 2016
  end-page: 25
  article-title: Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta‐analysis of prospective cohort studies
  publication-title: Osteoporos Int
– volume: 7
  start-page: 177
  year: 1986
  end-page: 88
  article-title: Meta‐analysis in clinical trials
  publication-title: Control Clin Trials
– volume: 291
  start-page: 228
  year: 2004
  end-page: 38
  article-title: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management
  publication-title: JAMA
– volume: 23
  start-page: 75
  year: 2008
  end-page: 85
  article-title: Risk factors for vertebral and nonvertebral fracture over 10 years: a population‐based study in women
  publication-title: J Bone Miner Res
– volume: 61
  start-page: 868
  year: 2013
  end-page: 74
  article-title: Thyroid status and 6‐year mortality in elderly people living in a mildly iodine‐deficient area: the aging in the Chianti Area Study
  publication-title: J Am Geriatr Soc
– volume: 68
  start-page: 175
  year: 2008
  end-page: 81
  article-title: Effects of serum TSH and FT4 levels and the TSHR‐Asp727Glu polymorphism on bone: the Rotterdam Study
  publication-title: Clin Endocrinol
– volume: 16
  start-page: 375
  year: 2006
  end-page: 80
  article-title: The impact of overt and subclinical hyperthyroidism on skeletal muscle
  publication-title: Thyroid
– volume: 97
  start-page: 1861
  year: 2012
  end-page: 70
  article-title: Clinical review. Risk factors for low bone mass‐related fractures in men: a systematic review and meta‐analysis
  publication-title: J Clin Endocrinol Metab
– volume: 28
  start-page: 472
  year: 2013
  end-page: 9
  article-title: A prospective study of thyroid function, bone loss, and fractures in older men: the MrOS study
  publication-title: J Bone Miner Res
– volume: 169
  start-page: 845
  year: 2013
  end-page: 52
  article-title: Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway
  publication-title: Eur J Endocrinol
– volume: 1
  start-page: 59
  year: 2013
  end-page: 70
  article-title: Glucocorticoid‐induced osteoporosis: mechanisms, management, and future perspectives
  publication-title: Lancet Diabetes Endocrinol
– volume: 68
  start-page: 259
  year: 2001
  end-page: 70
  article-title: A meta‐analysis of the effects of cigarette smoking on bone mineral density
  publication-title: Calcif Tissue Int
– volume: 22
  start-page: 490
  year: 2015
  end-page: 4
  article-title: Bone health after menopause
  publication-title: Curr Opin Endocrinol Diabetes Obes
– volume: 36
  start-page: 137
  year: 2014
  end-page: 47
  article-title: Negative spinal bone mineral density changes and subclinical ovulatory disturbances–prospective data in healthy premenopausal women with regular menstrual cycles
  publication-title: Epidemiol Rev
– volume: 29
  start-page: 76
  year: 2008
  end-page: 131
  article-title: The clinical significance of subclinical thyroid dysfunction
  publication-title: Endocr Rev
– volume: 95
  start-page: 3173
  year: 2010
  end-page: 81
  article-title: Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women
  publication-title: J Clin Endocrinol Metab
– volume: 11
  start-page: 15
  year: 2011
  article-title: Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men
  publication-title: BMC Endocr Disord
– volume: 20
  start-page: 1185
  year: 2005
  end-page: 94
  article-title: Predictive value of BMD for hip and other fractures
  publication-title: J Bone Miner Res
– volume: 140
  start-page: 128
  year: 2004
  end-page: 41
  article-title: Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. preventive services task force
  publication-title: Ann Intern Med
– volume: 100
  start-page: 4524
  year: 2015
  end-page: 32
  article-title: Subclinical thyroid dysfunction and frailty among older men
  publication-title: J Clin Endocrinol Metab
– volume: 30
  start-page: 898
  year: 2015
  end-page: 905
  article-title: The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register‐based time‐resolved cohort analysis
  publication-title: J Bone Miner Res
– volume: 313
  start-page: 1657
  year: 2015
  end-page: 65
  article-title: Preferred reporting items for systematic review and meta‐analyses of individual participant data: the PRISMA‐IPD statement
  publication-title: JAMA
– ident: e_1_2_9_20_1
  doi: 10.1016/S2213-8587(13)70045-7
– ident: e_1_2_9_12_1
  doi: 10.1001/jama.2015.3656
– ident: e_1_2_9_6_1
  doi: 10.1210/jcem.87.2.8182
– ident: e_1_2_9_36_1
  doi: 10.1210/jc.2014-1051
– ident: e_1_2_9_14_1
– ident: e_1_2_9_28_1
  doi: 10.1097/MED.0000000000000204
– ident: e_1_2_9_42_1
  doi: 10.1210/jc.2015-3191
– volume: 68
  start-page: 175
  year: 2008
  ident: e_1_2_9_35_1
  article-title: Effects of serum TSH and FT4 levels and the TSHR‐Asp727Glu polymorphism on bone: the Rotterdam Study
  publication-title: Clin Endocrinol
  doi: 10.1111/j.1365-2265.2007.03016.x
– ident: e_1_2_9_21_1
  doi: 10.1093/epirev/mxt012
– volume: 6
  start-page: 62
  year: 2007
  ident: e_1_2_9_39_1
  article-title: Subclinical hyperthyroidism of variable etiology and its influence on bone in postmenopausal women
  publication-title: Hormones (Athens)
– ident: e_1_2_9_2_1
  doi: 10.1056/NEJM199503233321202
– ident: e_1_2_9_19_1
  doi: 10.1038/nrendo.2015.71
– ident: e_1_2_9_17_1
  doi: 10.1001/jama.291.2.228
– ident: e_1_2_9_33_1
  doi: 10.1007/s00198-011-1768-x
– ident: e_1_2_9_40_1
  doi: 10.1016/j.beem.2011.12.004
– ident: e_1_2_9_24_1
  doi: 10.1136/bmj.c221
– ident: e_1_2_9_23_1
  doi: 10.1007/s00198-015-3259-y
– ident: e_1_2_9_4_1
  doi: 10.1089/105072503322238854
– ident: e_1_2_9_34_1
  doi: 10.1359/jbmr.070814
– ident: e_1_2_9_16_1
  doi: 10.1001/archinternmed.2012.402
– ident: e_1_2_9_31_1
  doi: 10.1530/EJE-13-0546
– ident: e_1_2_9_7_1
  doi: 10.1210/er.2006-0043
– ident: e_1_2_9_13_1
– ident: e_1_2_9_27_1
  doi: 10.1007/BF02390832
– ident: e_1_2_9_38_1
  doi: 10.1007/s00198-015-3221-z
– ident: e_1_2_9_29_1
  doi: 10.1016/0197-2456(86)90046-2
– ident: e_1_2_9_18_1
  doi: 10.7326/0003-4819-140-2-200401200-00015
– ident: e_1_2_9_43_1
  doi: 10.1016/j.cct.2005.05.006
– ident: e_1_2_9_8_1
  doi: 10.1001/jama.2015.5161
– ident: e_1_2_9_11_1
  doi: 10.1002/jbmr.1774
– ident: e_1_2_9_9_1
  doi: 10.1359/JBMR.050304
– ident: e_1_2_9_22_1
  doi: 10.1371/journal.pone.0081124
– ident: e_1_2_9_26_1
  doi: 10.1210/jc.2011-3058
– ident: e_1_2_9_25_1
  doi: 10.1191/1740774505cn087oa
– ident: e_1_2_9_30_1
  doi: 10.1093/eurheartj/ehu424
– ident: e_1_2_9_3_1
  doi: 10.1186/1472-6823-11-15
– ident: e_1_2_9_32_1
  doi: 10.1111/jgs.12267
– ident: e_1_2_9_41_1
  doi: 10.1089/thy.2006.16.375
– ident: e_1_2_9_10_1
  doi: 10.1016/0140-6736(93)92555-8
– ident: e_1_2_9_37_1
  doi: 10.1210/jc.2009-2630
– ident: e_1_2_9_5_1
  doi: 10.1002/jbmr.2416
– ident: e_1_2_9_15_1
  doi: 10.1001/jama.2010.1361
SSID ssj0013060
Score 2.4888282
SecondaryResourceType review_article
Snippet Background Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear....
Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear. To...
Background Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear....
Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 56
SubjectTerms Absorptiometry
Adults
Aged
Asymptomatic Diseases
Biomedical materials
Bone Density
Bone loss
Bone mineral density
Data analysis
Data processing
Dual energy X-ray absorptiometry
Female
Femur
Fractures
Fractures, Bone - etiology
Fractures, Bone - metabolism
Fractures, Bone - prevention & control
Health risk assessment
Hip
Humans
Hyperthyroidism
Hyperthyroidism - diagnosis
Hyperthyroidism - epidemiology
Hyperthyroidism - metabolism
Hypothyroidism
Hypothyroidism - diagnosis
Hypothyroidism - epidemiology
Hypothyroidism - metabolism
Male
prospective studies
Regression analysis
Risk Factors
Spine
Spine (lumbar)
Surgical implants
Thyroid
thyroid disease
Thyroid diseases
Thyroid gland
Thyroid-stimulating hormone
Thyroxine
Title Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.12688
https://www.ncbi.nlm.nih.gov/pubmed/29034571
https://www.proquest.com/docview/1978494121
https://www.proquest.com/docview/1951564919
https://pubmed.ncbi.nlm.nih.gov/PMC5739958
Volume 283
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEB5CDqWXdvvYNrvZotJeuuBg2ZJtQS9L25AGsgulgVyKsSyZmm7sJXYO2V_fkfxo0pRCezP2CEsajfSNNPMJ4C3VgeaeyhxXCt9hkionYSx0EBlLkbGMKmZyhxfXwWzJ5iu-GsD7Lhem4YfoN9yMZdj52hh4Iqt9Iy_z9YR6QWQyfakfGOL8j1-8X0cIrk0RRgjBnADXuZab1Ibx9EUPV6MjiHkcKbmPYO0SNH0M37rKN5EnPybbWk7S-994Hf-3dSfwqMWm5KoZTE9goIun8GDRnr4_g_WeLkkb4EWqreyyKwkqfVPmiqhdZdZLK5cUijTZxSTHUmWhyTq3VNdEmeD5emfeY5u6nE9i7uzd1NVzWE4_ff0wc9rrGpwUfbzICQMZaKVc3090mGmqNCodEWSUcKUj4UYpjyiTTEj0sXjmuwlFrIgOi9JSZWnkn8KwwFq8BILTkFAcPRnjwSnqJVq7mmZayFCiw6ZG8K5TW5y2XObmSo3buPdpsP9i238jeNPL3jUMHn-UGnfaj1srrmKKLjYTjHp0BK_7z2h_5lAlKXS5NTLc8O0IKkbwohks_W884fqMh1g6PBhGvYDh9j78UuTfLcc3D03OMVbr0o6Sv9Q8nt98Xtins38RPoeHiP2iZjdpDMN6s9UXiK9q-cra0U-fRyUf
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Rb9MwED6xITFeYMCAwjaM4AWkVHFiJ_YjQkzdWIeENmlvURw7IoKmqEkfxq_nzklDyxDS9hYlZ8X2-ezv7LvPAG-5S5yMbBmERseBMNwGuRBpgMjY6FKU3ArKHZ6eJZMLcXIpL_vYHMqF6fghhg03sgw_X5OB04b0upXPq9mYR4lSW3DXH9ARJvoa_TlECH2SMIIIESS40vXspD6QZyi7uR5dA5nXYyXXMaxfhI4edjetNp67kGJPvo-XrRkXv_5idrx1-3bhQQ9P2YduPD2CO65-DPem_QH8E5itqZP1MV6sWZpVgiVDvS_mlWX2qqEl08vltWVdgjGrsNS8dmxWebZrZil-vr2i99ioVdono2t7F22zBxdHn84_ToL-xoagQDdPBWliEmdtGMe5S0vHrUO9I4hUubRO6VAVUnFhhDboZskyDnOOcBF9FuuMLQsVP4XtGmvxHBjORNpKdGbIibM8yp0LHS-dNqlBn82O4N1Kb1nR05nTrRo_ssGtwf7LfP-N4M0g-7Mj8fin1P5K_VlvyE3G0csWWvCIj-D18BlNkM5V8trNlyQjiXJHcz2CZ91oGX4T6TAWMsXS6cY4GgSI3nvzS1198zTfMqW0Y6zWez9M_lPz7OTL8dQ_vbiJ8CvYmZxPT7PT47PPL-E-QkHVbS7tw3a7WLoDhFutOfRG9RvPXCk9
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVcoLwXChjBBaSs4sRObKmXCli1hS0IUakXFMUZR0Sw2Wo3eyi_vmPnwS5FSHCLkrHieDyeb-KZzwAvuU2sjLAMQqPjQBiOQS5EGhAyNroUJUfhaoenJ8nhqTg-k2dbsN_XwrT8EMMPN2cZfr12Bn6O5bqRz6vZmEeJUtfgukjITzpI9Dn6tYcQ-hphwhAiSMjRdeSkPo9naLvpjq5gzKupkusQ1vugyS342ve-TT35Pl41Zlz8_I3Y8X8_bxduduCUHbSz6TZs2foO7Ey77fe7MFtTJusyvNhyZfrySkZaX8wrZHixdA7Ty-U1sra8mFXUal5bNqs81zVDlz3fXLj79E190Sdzh_YumuU9OJ28-_LmMOjOawgKCvJUkCYmsYhhHOc2LS1HS1onCKlyiVbpUBVScWGENhRkyTIOc05gkSIWtAbLQsX3YbumXjwERuuQRkmhjAvhkEe5taHlpdUmNRSx4Qhe9WrLio7M3J2p8SMbghoav8yP3wheDLLnLYXHH6X2eu1nnRkvM04xttCCR3wEz4fHZIBuVyWv7XzlZKQj3NFcj-BBO1mG10Q6jIVMqXW6MY0GAUfuvfmkrr55km-ZuqJj6tZrP0v-0vPs-OPR1F89-hfhZ7Dz6e0k-3B08v4x3CAcqNo_S3uw3SxW9glhrcY89SZ1CUOnJ-w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+Subclinical+Thyroid+Dysfunction+and+Change+in+Bone+Mineral+Density+in+Prospective+Cohorts&rft.jtitle=Journal+of+internal+medicine&rft.au=Segna%2C+Daniel&rft.au=Bauer%2C+Douglas+C&rft.au=Feller%2C+Martin&rft.au=Schneider%2C+Claudio&rft.date=2018-01-01&rft.issn=0954-6820&rft.eissn=1365-2796&rft.volume=283&rft.issue=1&rft.spage=56&rft.epage=72&rft_id=info:doi/10.1111%2Fjoim.12688&rft_id=info%3Apmid%2F29034571&rft.externalDocID=PMC5739958
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-6820&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-6820&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-6820&client=summon